Critical evaluation of B and T cell markers in man

Expression of a functional Fas death receptor by human foetal motoneurons.

Neuroscience·2003

Structural and functional properties of membrane and secreted IgD.

Molecular immunology·2001

In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients.

Journal of neuroimmunology·2000

Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: a study of 89 patients.

Journal of autoimmunity·2000

Cross-reactivity of anti-galactocerebroside autoantibodies with a Trypanosoma brucei proteolipidic epitope.

Clinical and experimental immunology·2000

In vitro induction of nitric oxide synthase in astrocytes and microglia by Trypanosoma brucei brucei.

Parasite immunology·1999

Screening of cellular immunity in patients with rheumatoid arthritis by phytohaemagglutinin skin test.

Rheumatology·1975

Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.

Rheumatology·1975

Thermal inactivation and gradient studies of the active agent in rheumatoid arthritis.

Rheumatology·1975

Co-cultivation of human cell lines with synovial fluids of patients with rheumatoid arthritis.

Rheumatology·1975

Rheumatoid synovitis: complement and immune complexes.

Rheumatology·1975

Mycoplasmas and 'diphtheroids' in rheumatoid arthritis.

Rheumatology·1975

Hyper-Intense Tumor Peripheral Accumulation of Antibody-Conjugated Iron Oxide Nanoparticles can Enable Breast Cancer Detection by Magnetic Particle Imaging.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Concurrent Kaposi Sarcoma and B-cell Lymphoma in an HIV-Negative Patient: A Case Report.

Cureus·2026

A Tumor-Microenvironment-Responsive Chemically Masked IL‑2 Prodrug Potentiates PD‑1 Checkpoint Blockade and Elicits Robust Antitumor Efficacy.

ACS central science·2026

Nanotechnology-enabled immunomodulation in esophageal cancer: targeting the tumor microenvironment to overcome therapeutic barriers.

Frontiers in immunology·2026

Interpretation of p53 immunohistochemical stain of TP53-mutated myeloid neoplasms.

Frontiers in oncology·2026

miR-155-5p drives coordinated tumor and macrophage reprogramming across multiple cancer entities.

BMC medicine·2026

Related Experiment Videos

Critical evaluation of B and T cell markers in man

Related Concept Videos

Expression of a functional Fas death receptor by human foetal motoneurons.

Structural and functional properties of membrane and secreted IgD.

In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients.

Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: a study of 89 patients.

Cross-reactivity of anti-galactocerebroside autoantibodies with a Trypanosoma brucei proteolipidic epitope.

In vitro induction of nitric oxide synthase in astrocytes and microglia by Trypanosoma brucei brucei.

Screening of cellular immunity in patients with rheumatoid arthritis by phytohaemagglutinin skin test.

Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.

Thermal inactivation and gradient studies of the active agent in rheumatoid arthritis.

Co-cultivation of human cell lines with synovial fluids of patients with rheumatoid arthritis.

Rheumatoid synovitis: complement and immune complexes.

Mycoplasmas and 'diphtheroids' in rheumatoid arthritis.

Hyper-Intense Tumor Peripheral Accumulation of Antibody-Conjugated Iron Oxide Nanoparticles can Enable Breast Cancer Detection by Magnetic Particle Imaging.

Concurrent Kaposi Sarcoma and B-cell Lymphoma in an HIV-Negative Patient: A Case Report.

A Tumor-Microenvironment-Responsive Chemically Masked IL‑2 Prodrug Potentiates PD‑1 Checkpoint Blockade and Elicits Robust Antitumor Efficacy.

Nanotechnology-enabled immunomodulation in esophageal cancer: targeting the tumor microenvironment to overcome therapeutic barriers.

Interpretation of p53 immunohistochemical stain of TP53-mutated myeloid neoplasms.

miR-155-5p drives coordinated tumor and macrophage reprogramming across multiple cancer entities.

Related Experiment Videos

Critical evaluation of B and T cell markers in man

Related Concept Videos

Related Articles